Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 29 results:
Author Title [ Type(Asc)] Year
Filters: Author is Williams, R.  [Clear All Filters]
Journal Article
A. Pate, Barrowman, M., Webb, D., Pimenta, J. M., Davis, K. J., Williams, R., Van Staa, T., and Sperrin, M., Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect, BMJ Open Respir Res, vol. 5, p. e000339, 2018.
A. R. Tate, Dungey, S., Glew, S., Beloff, N., Williams, R., and Williams, T., Quality of recording of diabetes in the UK: how does the GP's method of coding clinical data affect incidence estimates? Cross-sectional study using the CPRD database, BMJ Open, vol. 7, p. e012905, 2017.
S. A. Julious, Horspool, M. J., Davis, S., Bradburn, M., Norman, P., Shephard, N., Cooper, C. L., Smithson, W. H., Boote, J., Elphick, H., Loban, A., Franklin, M., Kua, W. S., May, R., Campbell, J., Williams, R., Rex, S., and Bortolami, O., PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term - a cluster randomised controlled trial and economic evaluation, Health Technol Assess, vol. 20, pp. 1-154, 2016.
P. Korhonen, Heintjes, E. M., Williams, R., Hoti, F., Christopher, S., Majak, M., Kool-Houweling, L., Strongman, H., Linder, M., Dolin, P., and Bahmanyar, S., Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries, Bmj, vol. 354, p. i3903, 2016.
H. Strongman, Korhonen, P., Williams, R., Bahmanyar, S., Hoti, F., Christopher, S., Majak, M., Kool-Houweling, L., Linder, M., Dolin, P., and Heintjes, E. M., Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study, BMJ Open Diabetes Res Care, vol. 5, p. e000364, 2017.
H. Strongman, Christopher, S., Majak, M., Williams, R., Bahmanyar, S., Linder, M., Heintjes, E. M., Bennett, D., Korhonen, P., and Hoti, F., Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study, BMJ Open Diabetes Res Care, vol. 6, p. e000481, 2018.
K. Walters, Rait, G., Petersen, I., Williams, R., and Nazareth, I., Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database, Eur Heart J, vol. 29, pp. 2981-8, 2008.
R. Williams, Kothny, W., Serban, C., Lopez-Leon, S., and Schlienger, R., Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study, Endocrinol Diabetes Metab, vol. 2, p. e00052, 2019.
G. Glover, Williams, R., Tompkins, G., and Oyinlola, J., An observational study of the use of acute hospital care by people with intellectual disabilities in England, J Intellect Disabil Res, 2018.
G. Glover, Williams, R., Tompkins, G., and Oyinlola, J., An observational study of the use of acute hospital care by people with intellectual disabilities in England, J Intellect Disabil Res, vol. 63, pp. 85-99, 2019.
E. Gieling, de Vries, F., Williams, R., van Onzenoort, H. A. W., de Boer, A., V. Cate, T., Kramers, C., and Burden, A., Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists, Int J Clin Pharm, 2019.
G. Glover, Williams, R., Heslop, P., Oyinlola, J., and Grey, J., Mortality in people with intellectual disabilities in England, J Intellect Disabil Res, vol. 61, pp. 62-74, 2017.
C. Minassian, Williams, R., Meeraus, W. H., Smeeth, L., Campbell, O. M. R., and Thomas, S. L., Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database, Pharmacoepidemiol Drug Saf, vol. 28, pp. 923-933, 2019.
H. Strongman, Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., Dedman, D., Gallagher, A., Oyinlola, J., Kousoulis, A., and Valentine, J., Limitations for health research with restricted data collection from UK primary care, Pharmacoepidemiol Drug Saf, 2019.
C. Willame, Baril, L., van den Bosch, J., Ferreira, G. L., Williams, R., Rosillon, D., and Cohet, C., Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1397-1406, 2016.
J. Ride, Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., and Jacobs, R., Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness, Health Serv Res, 2019.
H. Carreira, Williams, R., Strongman, H., and Bhaskaran, K., Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review, BMJ Open, vol. 9, p. e029227, 2019.
R. E. Ghosh, Crellin, E., Beatty, S., Donegan, K., Myles, P., and Williams, R., How Clinical Practice Research Datalink data are used to support pharmacovigilance, Therapeutic Advances in Drug Safety, 2019.
W. Hollingworth, Biswas, M., Maishman, R. L., Dayer, M. J., McDonagh, T., Purdy, S., Reeves, B. C., Rogers, C. A., Williams, R., and Pufulete, M., The healthcare costs of heart failure during the last five years of life: A retrospective cohort study, Int J Cardiol, vol. 224, pp. 132-138, 2016.
M. Pufulete, Maishman, R., Dabner, L., Mohiuddin, S., Hollingworth, W., Rogers, C. A., Higgins, J., Dayer, M., Macleod, J., Purdy, S., McDonagh, T., Nightingale, A., Williams, R., and Reeves, B. C., Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model, Health Technol Assess, vol. 21, pp. 1-150, 2017.
J. Ride, Kasteridis, P., Gutacker, N., Kronenberg, C., Doran, T., Mason, A., Rice, N., Gravelle, H., Goddard, M., Kendrick, T., Siddiqi, N., Gilbody, S., Dare, C. R., Aylott, L., Williams, R., and Jacobs, R., Do care plans and annual reviews of physical health influence unplanned hospital utilisation for people with serious mental illness? Analysis of linked longitudinal primary and secondary healthcare records in England, BMJ Open, vol. 8, p. e023135, 2018.
den C. Heijer, Hoebe, C., Driessen, J. H., Wolffs, P., van den Broek, I., Hoenderboom, B., Williams, R., de Vries, F., and Dukers-Muijrers, N., Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients, Clinical Infectious Diseases, 2019.
R. Williams, de Vries, F., Kothny, W., Serban, C., Lopez-Leon, S., Chu, C., and Schlienger, R., Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study, Diabetes Obes Metab, vol. 19, pp. 1473-1478, 2017.
R. Williams, van Staa, T. P., Gallagher, A. M., Hammad, T., Leufkens, H. G. M., and de Vries, F., Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study, BMJ Open, vol. 8, p. e020827, 2018.
R. Williams, Kothny, W., Serban, C., Lopez-Leon, S., de Vries, F., and Schlienger, R., Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study, Endocrinol Diabetes Metab, vol. 2, p. e00084, 2019.
P. Kasteridis, Ride, J., Gutacker, N., Aylott, L., Dare, C., Doran, T., Gilbody, S., Goddard, M., Gravelle, H., Kendrick, T., Mason, A., Rice, N., Siddiqi, N., Williams, R., and Jacobs, R., Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England, Psychiatr Serv, p. appips201800504, 2019.
S. Padmanabhan, Carty, L., Cameron, E., Ghosh, R. E., Williams, R., and Strongman, H., Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications, Eur J Epidemiol, 2018.
H. Carreira, Williams, R., Muller, M., Harewood, R., and Bhaskaran, K., Adverse mental health outcomes in breast cancer survivors compared to women who did not have cancer: systematic review protocol, Syst Rev, vol. 6, p. 162, 2017.
L. A. Garcia Rodriguez, Williams, R., Derby, L. E., Dean, A. D., and Jick, H., Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors, Arch Intern Med, vol. 154, pp. 311-6, 1994.
[Page last reviewed 5 February 2020]